• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Heartbeam, Inc. - Common Stock (NQ: BEAT )

    2.430 +0.050 (+2.10%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 92,003
    Open 2.360
    Bid (Size) 2.410 (10)
    Ask (Size) 2.430 (1)
    Prev. Close 2.380
    Today's Range 2.320 - 2.520
    52wk Range 1.350 - 3.480
    Shares Outstanding 34,260,799
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures FDA Clearance for Innovative Arrhythmia Assessment Device
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety

    Performance

    YTD
    +4.29%
    +4.29%
    1 Month
    -12.90%
    -12.90%
    3 Month
    +19.12%
    +19.12%
    6 Month
    -0.41%
    -0.41%
    1 Year
    +11.47%
    +11.47%

    More News

    Read More
    BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Presents Positive Data for Groundbreaking Technology at AHA Conference
    Via Investor Brand Network
    HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Advances Toward Commercialization of Cardiac Care Technology with FDA Submissions and Key Leadership Appointments
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    HeartBeam Reports Third Quarter 2024 Results
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q3 Earnings Call with Key Regulatory and Initiative Updates
    Via Investor Brand Network
    Topics Earnings Intellectual Property
    Exposures Financial Intellectual Property
    HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Wins 2024 Digital Health Hub Award for Innovation in Cardiac Care
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards
    From HeartBeam, Inc.
    Via Business Wire
    Lifesaving Portable, AI Augmented Cardiac Monitoring Technology Poised for Commercial Launch Under New Industry Leader CEO: Heartbeam, Inc. (NASDAQ: BEAT)
    Via Get News
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    TechMediaBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Robert Eno as New CEO to Lead Next Phase of Growth and Innovation
    Via Investor Brand Network
    Topics Artificial Intelligence Intellectual Property
    Exposures Artificial Intelligence Intellectual Property Product Safety
    HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Industry Expert, Pioneer as New Chief AI Scientist
    Via Investor Brand Network
    Topics Artificial Intelligence Intellectual Property
    Exposures Artificial Intelligence Intellectual Property
    HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Industry Expert as New CFO
    Via Investor Brand Network
    Topics Intellectual Property Retirement
    Exposures Intellectual Property Pension
    HeartBeam Names Timothy Cruickshank as Chief Financial Officer
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q2 2024 Financial Report, Operational Update
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence Product Safety
    BEAT Stock Earnings: HeartBeam Misses EPS for Q2 2024
    Via InvestorPlace
    HeartBeam Reports Second Quarter 2024 Results
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces Conference Call, Webcast to Discuss Q2 Results
    Via Investor Brand Network
    HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Now Listed on Russell Microcap Index
    Via Investor Brand Network
    HeartBeam Added to Russell Microcap® Index
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces Positive Study Data for Its AI Program
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.